Introduction Acute myocardial infarction (AMI) is a common clinical presentation associated with high fatality. International guidelines on evidence-based treatments for AMI are well established. However, implementation of evidence-based medical practice varies and good adherence to AMI treatment guidelines is associated with improved patient outcomes. Implementation of clinical pathway has been shown to improve the adherence to AMI treatment guidelines but data on the beneficial effects of clinical pathway implementation on clinical outcomes of AMI is scarce. This study was designed to explore the impacts of clinical pathway implementation on AMI case fatality rate. (2/2007-1/2011 ) consecutive patients admitted for AMI to this Hospital were identified and analyzed; the in-hospital case fatality rate between the 2 groups was 14.6% (125/859) versus 10.9% (128/1170), p=0.015; the 30-day case fatality rate was 18.4% (157/853) versus 14.9% (172/1151), p=0.039; and the 6-month case fatality rate was 26.0% (221/849) versus 22.9% (262/1143), p=0.109, respectively. The reduction of in-hospital, 30-day and 6-month case fatality rate was statistically significant, with an odds ratio (OR) of 0.649 p=0.002; , p=0.002; OR 0.700 , p=0.002, respectively, after multivariate analysis. The 30-day and 6-month survival analysis using Cox regression model revealed a significant improvement in survival after implementation of AMI clinical pathway, p=0.002 and p=0.001, respectively. Length of in-hospital stay was significantly reduced from a mean of 5.81 days to 4.71 days between the 2 periods, p=<0.001.
Conclusions Implementation of AMI Clinical Pathway was associated with a significant reduction in AMI case fatality rate and better clinical outcomes. 
^^^^^^^^^^

STUDY OF TRACHEOSTOMIZED PATIENTS IN INTENSIVE CARE UNIT
Background
Tracheostomy is a common procedure performed in patients requiring prolonged mechanical ventilation in the critical care setting.
Objective The primary objective is to describe the short-term and long-term outcomes of tracheostomized Intensive Care Unit (ICU) patients. The secondary objective is to identify any predictors of complications during and after the tracheostomy procedure.
Design
Retrospective and prospective, observational case series performed in a general medical-surgical adult ICU in a local tertiary centre.
Intervention
None
Patients
The inclusion criteria were adult patients older than 18 years old admitted to the ICU of Pamela Youde Nethersole Eastern Hospital (PYNEH) with subsequent tracheostomy done during the observational period and those immediate post-operative cases. Exclusion criterion was patients already had a tracheostomy before current ICU admission.
Methods Medical records from July 2008 to December 2009 were reviewed in the retrospective part. Data were collected prospectively from July 2010 to June 2011. Intra-procedural complications of tracheostomy were recorded during the prospective period. Short-term complications were recorded in both periods, while long-term complications were retrieved from retrospective period. Functional outcome of tracheostomized and survived patients in the retrospective period were assessed in the form of Barthel Index (BI) via telephone contacts. Short Form-36 (SF-36) questionnaires were sent to survived patients to study their physical and mental function.
Results
A total of 153 patients were recruited. Among them, 99 were recruited retrospectively while 54 were recruited prospectively, which respectively represented 5.5% and 4.5% of total ICU admissions during the two study periods. The most common indication for tracheostomy was prolonged mechanical ventilation (72.6%), followed by failure of extubation (15%). The mean duration of intubation was 9.05 ± 6.48 days. Surgical tracheostomy was the predominant method used (73.9%). There were no statistically significant differences between surgical and percutaneous tracheostomy on the complication rate. Duration of percutaneous tracheostomy (8.33 ± 5.51 minutes) was significantly shorter than the duration of surgical tracheostomy (42.36 ± 20.33 minutes, p= 0.011). Minor bleeding was the most common short-term complication (10.5%) and tracheal stenosis was the most common long-term complication (5.1%). Multivariate analysis using logistic regression showed that hypertension (adjusted odds ratio 5.28, 95% CI 1.05-26.51, p= 0.044) and chronic renal failure (CRF) (adjusted odds ratio 17.56, 95% CI 2.87-107.42, p= 0.002) were independent risk factors for minor bleeding; while the need to reintubate within 48 hours after extubation (adjusted odds ratio 10.5, 95% CI 1.30-84.88, p= 0.027) was an independent risk factor for tracheal stenosis. CRF was independently associated with composite complications (minor bleeding and tracheal stenosis; odds ratio 13.63, 95% CI of 2. 47-75.16, p= 0.003) . Mental health score at 1 year or more was generally better than physical health score in this cohort of patients.
Conclusion
This observational case series described the short-term and long-term outcomes of tracheostomized patients from ICU. Minor bleeding occurred in 10.5% of patients and tracheal stenosis occurred in 5.1% of patients. Their long-term outcome was relatively poor, with mental health slightly better than physical health; they required various degrees of assistance in the activity of daily living, and most of them required rehabilitation upon hospital discharge. CRF was found to be associated with increased risk for composite complications compared with those without CRF. However due to the small number of patients suffering from CRF in this study, further investigations should be conducted to verify this finding. Objectives To study the clinical features, spectrum of microorganisms, treatment and outcomes of necrotizing fasciitis (NF) patients who required intensive care unit (ICU) admission.
^^^^^^^^^^
A STUDY OF NECROTIZING FASCIITIS PATIENTS ADMITTED TO THREE LOCAL INTENSIVE CARE UNITS
Methods The medical records of 90 patients, who had been admitted to the intensive care units of Queen Elizabeth Hospital, United Christian Hospital and Tseung Kwan O Hospital due to necrotizing fasciitis from January 2005 to December 2011, were reviewed retrospectively.
Results
The study population consisted of 63 males and 27 females. The mean age of the patients was 61.4 (± 14.4) years. Diabetes was the most common comorbidity of NF. Majority of the cases were idiopathic in etiology (n=50; 55.6%). Extremities NF (n=67; 74.4%) occurred more frequently than central NF (n=23; 25.6%). Vibrio was the most prevalent microorganism isolated (n=20). The median time of diagnosis, counted from onset of symptoms, was 59 (42.8 -82 .0) hours. The median time of the first operation, counted from hospital admission, was 14 (6.1 -26.0) hours. 76 patients had received surgical debridement. Amputation was performed in 43 cases. The median time of ICU admission was 14 (7.5 -30.5) hours and the median APACHEⅡscore was 19 (15 -23). Most patients developed disseminated intravascular coagulopathy (n=78; 86.7%). The ICU mortality was 34.4% (n=31) and the hospital mortality was 46.7% (n=42). The median length of stay in ICU was 9 (4 -15) days and the median length of stay in hospital was 23.5 (12.8 -49.0) days. The age, serum lactate, APACHEⅡscore were significantly higher in the non-survivors. The time of diagnosis and operation were significantly delayed in the non-survivors. Bacteraemia, debridement < 3 times, operation > 24 hours after admission and presence of organ failure were significantly associated with mortality.
Conclusion
Marine microorganism (Vibrio spp. and Aeromonas spp.) was the most prevalent type of microorganism found in this study. Early diagnosis, early operation and adequate surgical debridement were important in the management of NF. NF patient should receive debridement ≥ 3 times and the operation should be performed within 24 hours after admission, as they were shown to be associated with lower mortality in this study. ^^^^^^^^^^ 
POST ABDOMINAL AORTIC ANEURSYM REPAIR
Background
Patients with open repair of abdominal aortic aneurysms (AAAs) are generally considered as high risk for significant peri-operative morbidity and mortality. With the introduction of endovascular repair (EVAR) technique, the clinical practice is changing. EVAR has been shown to have peri-operative survival benefit and reduction in complications in previous trials; while these advantages are not sustained in the long-term. Studies comparing the post-operative events and the long-term outcomes of EVAR and open repair of AAAs in local intensive care units are, however, lacking.
Method This is a retrospective study. Clinical outcomes in terms of peri-operative complications, mortality, 1-year survival and reterinvention rates were compared among propensity-score-matched patients after elective EVAR and open repair during 2007 -2011 period in Queen Elizabeth Hospital. Epidemiological data of patients with emergency AAA repair were also reviewed.
Results
74 and 40 patients received elective EVAR and open repair of AAAs, respectively. 35 patients from each group were selected to create the propensity-matched cohorts. The average age of the patients was 72.4 years, with mean aneurysm diameter of 61.7 mm. The operative mortality was lower after EVAR than open repair (0% versus 5.7%, P = 0.151). EVAR was associated with reduction in renal complication (2.9% versus 22.9%, P = 0.012) with OR of 0.09 (95% CI, 0.01 -0.80); and cardiac complication (14.3% versus 31.4%, P = 0.088) with OR of 0.29 (95% CI, 0.08 -1.01). Early survival advantage of EVAR was lost beyond 8 months, resulting in similar 1-year survival rate among the two groups at 91.4%. 46 patients underwent emergency AAA repair with average age of 77.9 years and mean aneurysm diameter of 70.0 mm. The 30-day operative mortality rate was 23.9% (32.4% after adjustment for rupture aneurysm repair). Peri-operative complications were common (cardiac: 60.9%, pulmonary: 45.7%, and renal: 56.5%). The 1-year survival rate was 52.2%.
Conclusions
The findings confirm the peri-operative advantages of endovascular over open approach for elective AAA repair in the patients in this local centre. The survival curves convergence on subsequent follow-up was likely due to the "catch-up" of cardiovascular events among patients with EVAR. Peri-operative medical therapy optimization and post-operative close monitoring may lead to longer sustainment of the early benefits of EVAR. After all, long-term data are necessary to evaluate the relative merits of both procedures in this locality. Objective To evaluate the pattern of readmission to intensive care unit (ICU) in a local hospital and identify patients at risk of unplanned ICU readmission.
^^^^^^^^^^
CHARACTERISTICS OF PATIENTS READMITTED TO INTENSIVE CARE UNIT: A CASE-CONTROL STUDY
Design A single-center nested case-control study in a mixed medical-surgical adult intensive care unit in a tertiary regional hospital
Interventions None
Measurements and main results Total 146 patients with unplanned readmission to the ICU of Pamela Youde Nethersole Eastern Hospital between 1 January 2008 and 30 June 2010 were studied and compared to 292 control patients who were discharged from ICU alive and never readmitted during the same hospitalization. Case and control were matched for age, gender and Acute Physiology and Chronic Health Evaluation (APACHE) IV risk of death. Patients' demographics parameters, physiological status and laboratory data were collected. Reason for readmission was determined from the medical record. During this 30-month period, the ICU readmission rate was 5.13% and the early readmission rate (defined as readmission within 72 hours of ICU discharge) was 2.32%. Mortality in readmitted patients was 30.8% compared to 6.8% in control (p<0.001). Mean hospital length of stay of readmitted group was 3 times of control (67.25 ± 66.43 Vs 22.16 ± 25.04 days, p<0.001). Deterioration of respiratory condition was the commonest cause of ICU readmission. Based on tree analysis, post-operative patients with sepsis (adjusted p=0.043), non-post-operative septic patients with significant fluid gain 24 hours before ICU discharge (adjusted p=0.013) and non-septic patient presented with increased sputum quantity on ICU discharge (adjusted p=0.012) were significantly associated with ICU readmission. In logistic regression analysis, presence of pneumonia during index admission was associated with ICU readmission due to worsening of pre-existing condition (adjusted OR=5.638, 95% C.I. 2.260-14.069, p=0.002).
Conclusion
The result highlighted the importance of good pulmonary care of critically ill patients. Incomplete resolution of respiratory conditions remained an important reason for potentially preventable ICU readmission. Attention to patient's fluid balance and sputum quantity before ICU discharge might help to prevent unplanned ICU readmission. 
^^^^^^^^^^
BULLOUS PEMPHIGOID: A REVIEW OF PATIENTS MANAGED IN HOSPITAL AND ITS RISK FACTORS FOR POOR PROGNOSIS AND EARLY MORTALITY
Background
Bullous pemphigoid (BP) is the most common autoimmune blistering disease, especially in the elderly. Its severity and case-fatality has been under-estimated, and local data on treatment and prognosis are lacking.
Objective
To evaluate the disease characteristics, comorbidities, in-patient treatment and morbidity, and to analyse the risk factors for flare-up and early mortality in Chinese patients that are hospitalised for BP.
Methodology
A retrospective cohort of patients with newly-diagnosed BP managed in the Prince of Wales Hospital from January 1, 2002 to December 31, 2011 was analysed.
Results
Of the 121 patients analysed, the mean age of onset was 79.9 years, with equal sex ratio. 81% had generalised BP. Most patients had poor premorbid status (78%) and multiple medical comorbidities (95%), with hypertension, cerebrovascular disease and diabetes being most common. First line treatment with systemic prednisolone 0.5mg/kg (mean 25.2mg, range 10-70, SD 8.1) was given to 91% of the patients. Adjuvant immunosuppressants were given to 13.2%. Treatment-related infective complications occurred in 66%. Flare-up occurred in 42% and was associated with delayed initial remission (p=0.017), use of immunosuppressants (p=0.002) and rapid tapering of steroid early in the course of disease (p<0.001). The average duration of survival after diagnosis was 18 months (95% CI 10.8-25.2 months). First-year mortality rate was 41.5%. Using Cox regression for multivariate analysis, the risk factors associated with early mortality after hospitalisation were, bed-bound status (HR 2.35, p=0.015), presence of malignancy (HR 5.31, p=<0 .001), anaemia (HR 1.65, p=0.044) and hypoalbuminaemia (HR 4.61, p=0.037) . However, patients with use of immunosuppressants (HR 0.2, p=0.037) or had history of flare-up (HR 0.58, p=0.029) seemed to fare better against early mortality. Background Vitiligo is a depigmentary skin disorder which is disfiguring and can cause significant psychological distress. Topical corticosteroid is the most commonly prescribed treatment, but it is not often effective and prolonged use may lead to skin atrophy and other side effects. Therefore, there are needs for searching other topical treatment options for vitiligo. Previous studies showed that topical tacrolimus can induce repigmentation in patients with vitiligo with no severe adverse effect reported.
Conclusion
Objective To assess the efficacy of topical tacrolimus ointment in treating patients with vitiligo who failed to respond to topical steroid.
Methods A prospective study was performed in 30 patients with vitiligo who do not respond to topical steroid. Two lesions were selected from each patients, one lesion was selected as target lesion and was treated with 0.1% tacrolimus ointment for 24 weeks and another lesion was selected as control area with no active treatment during the study period. Percentage of repigmentation and degree of repigmentation in term of visual analogue scale were documented. However majority of the data came from the Caucasians. In this dissertation, two studies were reported. The first study focused on the prevalence and correlates of depression and diabetes distress in type 2 diabetic patients. 189 type 2 diabetic patients were recruited from a teaching hospital; depression and diabetes distress were assessed by self-administered questionnaires. 10% of the subjects had depression and more than one third had diabetes distress. Depression was associated with obesity, emotional distress and lower quality of life. Furthermore, patients with concomitant depression and diabetes distress had poorer glycaemic control and more centrally obese. As presented in second study, which data were collected from the Hong Kong Diabetes Registry, after a mean follow up of 7 years, depression was also associated with 2-3 fold increased risk of incident cardiovascular disease especially stroke. Given the high prevalence of depression and associated poorer clinical outcomes, screening for depression was suggested as part of the standard care in type 2 diabetes. 
Introduction
Accumulation of advanced glycation endproducts (AGEs) is implicated in aging and the pathogenesis of diabetic complications, and is quantifiable by skin autofluorescence (AF) using the AGE Reader TM (DiagnOptics BV, Netherlands).
Objectives This cross-sectional study aimed to determine skin AF among healthy and diabetic subjects and to investigate the relationships between skin AF and microvascular complications in type 2 diabetic subjects.
Methods Subjects were recruited from the on-going population-based Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) 4 and the Diabetic Complication Assessment Program (DCAP), Queen Mary Hospital. Skin AF was measured and anthropometric and biochemical data including body height and weight, blood pressure, fasting glucose and lipids, and hemoglobin A1c were collected. Statistical analysis was performed with SPSS 19.0 using Pearson's correlation, chi-square test, one-way ANOVA, Kruskal-Wallis test, multiple linear regression, multiple logistic regressions, and receiver-operating characteristic (ROC) curves, as appropriate. The protocols were approved by the HKU/HKWC Ethics Committee and subjects were studied after informed consent.
Results Skin AF was measured in 457 subjects (235 male, 222 female; 57.1±10.2 years) from the CRISPS-4 cohort and in 322 type 2 diabetic subjects (192 male, 130 female, 63.9±11.0 years) from the DCAP cohort. Skin AF increased with age and was independently associated with the presence of nephropathy and neuropathy. The optimal AF cut-off value for discrimination was 2.263 AU on ROC analysis.
Conclusion
The reference range of skin AF was determined for our population and the association between skin AF has been demonstrated. The AGE Reader TM might serve as a simple and non-invasive method to stratify microvascular risks of diabetic subjects. ^^^^^^^^^^ 
ASSESSMENT OF LIVER FIBROSIS WITH TRANSIENT ELASTOGRAPHY (TE) AND NON-INVASIVE CLINICAL FORMULAE IN PATIENTS TREATED WITH METHOTREXATE FOR PSORIATIC ARTHROPATHY AND RHEUMATIOD ARTHRITIS
Background
Methotrexate is often used in the treatment of psoriasis and rheumatoid arthritis. There are ongoing controversies in the prevalence and severity of its hepatotoxic side-effects. Risk factors which have been identified to be associated with methotrexate hepatotoxicity include psoriasis, type 2 diabetes, obesity, excessive alcohol use and total cumulative dose. Liver biopsy remains the 'gold standard' for liver fibrosis evaluation. However, it is invasive and many patients do not accept its inherent risks. On the other hand, there are evolving evidence on the use of non-invasive methods in assessing methotrexate hepatotoxicity.
Methods In this prospective study, patients with chronic viral hepatitis B and C were excluded. Transient elastography (FibroScan) and three clinical prediction formulae: AST to platelet ratio index (APRI), AST to ALT ratio (AST/ALT) and FIB4 were used to evaluate liver fibrosis in psoriasis and rheumatoid arthritis patients on methotrexate. The effect of different risk factors in causing significant liver fibrosis (defined as FibroScan ≥7.9kPa) and determinants for liver stiffness were studied. Histological features of liver biopsy in patients with significant liver fibrosis were reported.
Results
A total of 128 subjects were included in this study. The prevalence of significant fibrosis by FibroScan ≥7.9kPa, APRI >0.5, AST/ALT >0.8 and FIB4 >1.3 were 4.9%, 7.8%, 85.2% and 35.2% respectively. Clinical prediction formulae did not show a positive correlation with FibroScan value. In evaluating the six patients with FibroScan ≥7.9kPa, all patients had cumulative dose of methotrexate more than 1500mg, but on multivariate analysis, hypertension was the only independent risk factor associated with significant liver fibrosis (OR = 11.02, 95%CI: 1.130-107.503, p = 0.039). Determinants of liver stiffness were age (β = 0.058; p < 0.001), psoriasis (β = 0.947; p = 0.022), methotrexate regime adjusted due to abnormal liver biochemistries (β = 1.188, p = 0.003) and insulin resistance (β = 0.815; p = 0.043). Liver biopsy was performed on 2 patients with FibroScan ≥7.9kPa with findings of mild peri-portal fibrosis and mild steatosis (Roenigk grade IIIa).
Conclusion
Significant liver fibrosis and cirrhosis are not common in methotrexate-treated patients. The cumulative dose of methotrexate is probably not associated with significant fibrosis but this requires further elucidation with a larger sample. Patients with risk factors should be monitored closely with non-invasive methods with good performance in diagnosing significant fibrosis.
^^^^^^^^^^
OVERVIEW OF CROHN'S DISEASE IN THE HONG KONG CHINESE POPULATION: A HOSPITAL-BASED STUDY Dr Lam Sing, Department of Medicine, Queen Elizabeth Hospital (June 2012 Gastroenterology and Hepatology Exit Assessment Exercise)
Background
Crohn's disease (CD) is a chronic and relapsing disorder characterized by inflammation destruction of any part and any layer of the gastrointestinal tract, leading to substantial adverse impacts on health, quality of life and medical costs. Consistent clinical data and trials on the treatment of CD regarding Hong Kong Chinese population are still limited as it remains an uncommon disease in our locality.
Objectives The aim of the study was to evaluate the demographics, epidemiology, treatment modalities and clinical outcomes of local Chinese CD patients in two Hong Kong regional hospitals.
Methods All Chinese CD patients attended the gastroenterology clinics in Queen Elizabeth Hospital (QEH) and Pamela Youde Nethersole Eastern Hospital (PYNEH) between January 2001 and December 2010 were recruited for study. Their clinical characteristics and disease outcomes were retrospectively analyzed. Patients were classified according to the Montreal classification. Factors associated with steroid dependency and bowel resection were identified by multivariate analysis. The cumulative probabilities of clinical outcomes including primary bowel resection and mortality were calculated.
Results
A total of 125 Chinese CD patients were recruited. 93 cases were diagnosed during the study period. The average incidence rate from 2000 to 2010 was 0.84/100,000 and there was no particular trend observed. The median follow-up period was 68 months. 72 patients (57.6%) were male (M:F=1.3:1) and the median age at diagnosis was 29 years (range 10-84). Most of the studied patients had ileocolonic CD (63.2%) and non-stricturing non-penetrating disease behavior (47.2%).
35 patients (28%) had upper gastrointestinal tract (L4) involvement and were associated with higher complication rates (p=0.000). Steroid dependency was associated with stricturing (OR: 8.11, 95%CI 1.73-37.84, p=0.008) or penetrating (OR 6.66, p=0 .014) disease behavior. Patients with colonic CD were less likely to have bowel resection (OR: 0.13, 95%CI 0.03-0.70, p=0.018) while penetrating disease behavior was associated with a higher chance (OR: 4.75, 95%CI 1.86-12.15, p=0.001). The cumulative probability of bowel resection was 39.5% and the cumulative survival rate was 95.2% at 10 years after diagnosis.
Conclusion
CD is an uncommon disease in Hong Kong Chinese population and clinical characteristics varies from the western countries. Patients with factors associated with worse outcome including stricturing or penetrating disease behavior, non-colonic disease location and presence of upper gastrointestinal tract involvement should be considered for an early aggressive treatment. 
^^^^^^^^^^
SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOSIS: A RETROSPECTIVE STUDY OF PREDICTORS FOR THE 30-DAYS MORTALITY IN A LOCAL CENTRE OF HONG KONG
Background
Spontaneous bacterial peritonitis is a common and severe infection among cirrhotic patients. Many different studies were performed throughout recent two decades trying to identify the predictors of mortality but a consensus could not be drawn yet. Besides, local data on the natural history of the disease are limited.
Objective This retrospective study intended to find the independent predictors of 30 days mortality among the local patients who suffered from spontaneous bacterial peritonitis in a single centre of Hong Kong.
Methods From January 2000 to October 2010, records of cirrhotic patients who were admitted to North District Hospital with the diagnosis of spontaneous bacterial peritonitis were reviewed retrospectively. The diagnosis was defined by polymorphonuclear cell count greater than or equal to 250/mm3 in ascitic fluid with or without a positive bacterial culture, in the absence of evidence suggesting of secondary peritonitis. Predictors of mortality were identified through logistic regression analysis.
Results
132 cirrhotic patients with 161 episodes of confirmed spontaneous bacterial peritonitis were identified. Their mean age was 65.6 with male predominant (68.9%). All patients were categorized to be Child-Turcotte-Pugh (CTP) class B (33.3%) and C (66.7%). Mean score of Model for End-stage Liver Disease (MELD) was 20.7. The 30 days mortality rate was 51% and the causes of death were: liver failure (41.2%), spontaneous bacterial peritonitis with sepsis (38.3%), hepatocellular carcinoma (16.1%), variceal bleeding (2.9%) and pneumonia (1.5%). Independent predictors of mortality were: background hepatocellular carcinoma (p=0.006, OR 9.95 with a 95% CI 1.72-54.06), higher CTP Class with class C versus B (p=0.025, OR 5.93 with a 95% CI 1.25-28.13), MELD score higher than 20 (p=0.035, OR 5.96 with a 95% CI 1.36-31.42), and renal dysfunction (p=0.029, OR 4.93 with a 95% CI 1.15-13.85).
Conclusions
Cirrhotic patients suffered from spontaneous bacterial peritonitis remained to have high mortality. Patients with background hepatocellular carcinoma, CTP class C, MELD score higher than 20 and renal dysfunction were associated with short term mortality. In high risk patients, practice of preventing renal dysfunction by intravenous albumin and broadening of empirical antibiotic are potentially modifiable and may improve prognosis. After resolution of spontaneous bacterial peritonitis, the patient should be given antibiotic prophylaxis and evaluated for orthotropic liver transplantation. ^^^^^^^^^^ Background With the widespread use of cross-sectional imaging and improvement in imaging sensitivity, incidentally discovered pancreatic cysts are being identified more frequently. Some incidental pancreatic cysts would have malignant potential and will progress over time. However, the natural history of incidental pancreatic cyst is relatively unknown and the optimal imaging surveillance interval for this low risk lesion is not well defined.
CHARACTERISTICS AND OUTCOME OF INCIDENTAL PANCREATIC CYSTS LESS THAN 3CM -EXPERIENCE FROM A REGIONAL HOSPITAL IN HONG KONG
Objectives 1) To determine the natural history of incidental pancreatic cysts with initial size less than 3cm and to determine the factors associated with cyst growth during imaging surveillance.
2) To evaluate a safe and optimal imaging surveillance interval based on observational result.
Methodology and analysis
This is a retrospective study examining all patients with incidental pancreatic cysts detected by computed-tomography (CT) imaging from January 2000 to December 2010. A computerized search through the radiology database which contained all the radiological examinations and reports was performed. Patients with incidental, asymptomatic pancreatic cysts less than 3cm in size at presentation with follow-up interval more than 3 months were included for analysis. Patients with history of pancreatitis, pancreatic pseudocyst and systemic cystic disease were excluded. The demographic, biochemical data and radiological features of pancreatic cysts at presentation were reviewed. Study outcomes include increased in cyst size, development of new cystic features, development of symptoms related to pancreatic cyst, malignant transformation and death related to cystic neoplasm of pancreas.
Results
Ninty-nine patients with asymptomatic, incidental pancreatic cyst less than 3cm were identified. The mean age was 66. The male to female ratio was 1:1. Over 80% of patients had one or more medical comorbidities and 50% of them had underlying non-pancreatic malignancy. The most common indication for imaging that detected incidental pancreatic cyst was staging for newly diagnosed malignancy (25.3%). Most patients (89.9%) had normal liver function test on presentation. The initial mean cyst size was 14.19mm, with 66% located over pancreatic body or tail region. Septation was present in nine patients (9.1%) while no patients had mural nodule. Over a mean follow-up duration of 22.2 months, eighty-two (82.8%) patients with pancreatic cysts did not show any significant growth, development of new cystic features or new symptom related to pancreatic cysts. By using multivariate logistic regression analysis, presence of septation (OR 5.291, 95% CI 1.076-25.6, p=0.040) and longer radiological follow-up duration (OR 1.054, 95% CI 1.023-1.086, p=0.001) were independently associated with cyst progression. Among seventeen (17.2%) patients with pancreatic cysts showed significant growth, malignant intraductal papillary mucinous neoplasm (IPMN) with metastasis was diagnosed in one (1.0%) patient after 54 months follow-up evaluation. The remaining cases were either within surgically resectable stage or clinically benign lesions. The majority of cyst growth occurred after 18 months from baseline evaluation. Thirty eight (38.4%) patients died during the study period. Only 1 (1.0%) patient died of malignant cystic neoplasm of pancreas after 54 months of follow-up evaluation. The remaining patients died of causes unrelated to pancreatic disease.
Conclusions
Most incidental pancreatic cysts less than 3cm did not have significant growth during follow-up. Mortality rate related to pancreatic cystic neoplasm was 1% in our study population. It is safe to adopt a conservative approach with regular imaging surveillance to patients with incidental pancreatic cyst less than 3cm. The interval of follow-up imaging at 12 months after baseline evaluation is a safe and reasonable duration, especially for cystic lesions without septation. 
^^^^^^^^^^
A REVIEW OF TEN YEARS EXPERIENCE OF LIVER CANCER TREATMENT WITH TRANSARTERIAL CHEMOEMBOLIZATION IN A DISTRICT HOSPITAL
Background
Transarterial chemoembolization (TACE) was widely used for the treatment of unresectable hepatocellular carcinoma (HCC). Recent evidence suggested that supplementing TACE with percutaneous ethanol injection (PEI) may improve survival.
Objective To determine the survival of patients treated with TACE, and to identify the factors associated with survival and TACE complication.
Methods 153 unresectable HCC patients treated with TACE (106 patients received TACE alone, 47 patients received TACE and supplementary PEI) during a 10 years period in Caritas Medical Centre were studied retrospectively. Survival was estimated by Kaplan-Meier method and compared by the log-rank test. Significant variables identified by univariate analysis were subjected to multivariate analysis by Cox proportional hazard model. Prognostic factors were evaluated.
Results
802 sessions of TACE were performed for 153 patients. The median survival was 16 months. The one-, three-and five-years survival rates were 62%, 14% and 7%. In subgroup analysis, patients receiving TACE with supplementary PEI had higher one-, three-and five-years survival rate of 87%, 19% and 13% respectively (p = 0.002). Multivariate analysis showed that HCC rupture before TACE (p < 0.001), AFP > 400 ng/ml (p < 0.001), ALT > 80 U/L (p = 0.006) were adversely associated with survival while TACE with supplementary PEI was associated with longer survival (p=0.002). The 30-day mortality was 7% (11 out of 153 patients). 16 patients (10.5%) developed post-TACE acute liver decompensation. Multivariate analysis revealed baseline ALT (p = 0.028), Child-Pugh B (p = 0.013) and first TACE (p = 0.001) were independent risk factors associated with post-TACE acute liver decompensation.
Conclusion
TACE was an effective palliative treatment for patients with unresectable HCC. Patients treated with TACE and supplementary PEI had a longer survival than those treated with TACE alone. Post-TACE acute liver decompensation was the commonest complication. Baseline ALT, Child-Pugh B and first TACE were independent predictors of such complication. 
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GASTRO-OESOPHAGEAL REFLUX DISEASE -A DECADE LATER: SIGNIFICANT DIRECT AND INDIRECT ECONOMIC COSTS IN AN ETHNIC CHINESE POPULATION
Background
Population based data tracking the healthcare utilisation of gastro-oesophageal reflux disease in Chinese subjects is scant. The healthcare utilisation in patients with gastro-oesophageal reflux disease was studied. Risk factors associated with healthcare utilization and types of healthcare access were identified. Rates of absenteeism and presenteeism were also examined.
Method 3360 Hong Kong ethnic Chinese subjects were polled in a telephone survey using a validated gastro-oesophageal reflux disease questionnaire, the Hospital Anxiety and Depression Scale, and the Validated Chinese SF-12.
Results A total of 2130 subjects (63.1% female, mean age 48.1 +/-18.2 years) completed the survey (response rate 62.8%). The annual, monthly and weekly prevalence rates of GERD were 36.5%, 12.2% and 4.2% respectively. This represents a statistical increase in prevalence over the last decade when compared to results from 2002. Annual rates of gastro-esophageal reflux as measured by the validated Chinese gastro-eosophageal reflux questionnaire (cGERDQ) was 20.5%. Patients with gastro-esophageal reflux utilised healthcare resources more frequently with 48.7% accessing either ambulatory care consultation, the accident and emergency department, requiring inpatient admission or purchasing prescription medication (OR 1.85, 95% CI, 1.6-2.1) compared to those who had no symptoms of gastro-eosophageal reflux. Severity and frequency of heartburn, acid regurgitation and a feeling of acidity in the epigastrium were independent risk factors for health care utilization in subjects with survey diagnosed gastro-esophageal reflux as were female gender, globus, hoarse voice, anxiety and social morbidity. Finally, subjects with gastro-esophageal reflux were found to have proportionally more absenteeism and presenteeism than subjects without.
Conclusion Gastro-esophageal reflux is associated with significant direct and indirect economic costs. The scale of the likely cost of healthcare for patients with gastro-esophageal reflux in the ethnic Chinese is significant. Moreover as the prevalence of gastro-esophageal reflux has increased over time, the costs attached to managing gastro-esophageal reflux are likely to have escalated. Results Meningitis in elderly were predominately bacterial or tuberculous in nature and they account for 60% of cases (37.1% and 22.9% respectively). Poor outcome was observed in 62.7% of patients and they have longer average length of stay (median 46, inter-quartile range 22 -64) and rate of institutionalization (30.0%). Elderly are less likely to present with headache (31.4%), present with at least 2 out of 4 typical features (48.6%, and achieve good outcome (35.3%). They are more likely to present with decreased consciousness (60.0%), have delay in diagnosis (65.7%) and have inpatient mortality (42.1%). Complications were also more common among elderly. Background Empirical use of broad-spectrum antibiotics is advocated for older patients at high risk of multidrug-resistant (MDR) bacterial infection, in particular nursing home residents. Bacterial and viral pneumonia are treated differently so earlier identification of viral pneumonia helps clinicians on selection of appropriate antimicrobials.
^^^^^^^^^^
MENINGITIS OF ELDERLY IN HONG KONG
Conclusion
Objective This study described etiological diagnoses of CAP in older patients and determined independent predictors of viral pneumonia. It also examined the relationship between establishing infective etiology and in-hospital mortality.
Patients and Methods A prospective cohort study was conducted in the medical unit of a university teaching hospital from October 2009 to September 2010. The study subjects were older patients hospitalized for CAP confirmed by chest radiographs.
Results A total of 488 patients were included, of whom 282 (38.6%) were male and 116 (23.8%) were living in nursing home. The mean age was 80.0 ± 7.9 years. Infective causes were identified in 137 (28.1%) patients. Bacterial, viral and mixed infections were detected in 86 (17.6%), 41 (8.4%) and 10 (2.0%) patients respectively. Nursing home-acquired pneumonia (NHAP) was most commonly caused by viral infection (55.9%). Bacterial infection was the most frequent (69.9%) cause of CAP in older patients living in the community. MDR bacterial infection was found in six patients. The strongest predictor of viral pneumonia was nursing home residence (OR 7.430), followed by female gender (OR 3.475), confusion (OR 3.858) and serum albumin level (OR 1.197) . No significant differences in in-hospital mortality were found in patients with and without etiological diagnosis established (14.6% v.s. 11.7%, P=0.381) as well as in those with viral and bacterial pneumonia (17.1% v.s. 12.8%, P=0.518). Objective To review the value of CSF biomarkers in the diagnosis of Alzheimer's disease (AD) and to evaluate the feasibility of using CSF biomarkers in the diagnosis AD patients in a local pilot study.
Methodology
In the systematic review, Medline, PubMed, and Cochrane Library were searched for internationally published English language journals, using the terms 'biomarkers', 'CSF', 'cerebrospinal fluid', 'Alzheimer's disease', 'dementia'. We identified 298 articles for further review. 128 articles were excluded and 170 articles into our review. In the cross-sectional study, we recruited both AD patients and non-AD subjects. AD subjects were diagnosed in accordance to the NINCDS-ADRDA criteria, and non-AD control subjects did not fulfil these AD criteria. The research protocol was approved by the HKU/HA HKW IRB, and written informed consents were obtained from all subjects. CSF samples were obtained by lumbar punctures, and were stored at -80 oC until assay. The three CSF biomarkers (Aß-42, tau and p-tau 181) were assayed by ELISA, using commercial kits (INNOTEST® hTau Ag, INNOTEST® PHOSPHO-TAU (181P), INNOTEST® ß-AMYLOID1-42; supplied by Innogenetics NV, Belgium). The levels of the CSF biomarkers were compared between the AD and non-AD, using Mann-Whitney U test. Multivariate logistic regression of each biomarker (adjusted for age and gender) was then performed.
Results
From the systematic review, there have been evidences supporting the usefulness of CSF biomarkers i.e. Aß-42, t-tau & p-tau 181 and their ratios in the accurate diagnosis of AD. Current researches are now focusing on the usage of CSF biomarkers in identifying the prodromal or pre-symptomatic AD subjects which will be good candidates for future drug trial. Quality assurance and standardization in CSF biomarkers processing and measurements are of great importance in the future for comparison of results between centers. For the cross sectional study, among 34 subjects recruited, 19 had AD and 15 had non-AD (5 cognitively normal and 10 non-AD dementia). The mean age of AD and non-AD subjects were 81.3+/-8.3 and 76.3+/-7.8 years (p=0.088), respectively. The intra-assay coefficient of variation (CV %) were 3.2%, 1.4% and 7.6% for t-tau, p-tau 181 and Aß-42, respectively. In bivariate analyses, there were no significant differences in the t-tau and p-tau levels between the two groups. For Aß-42, a non-significant trend was present (p = 0.06), with a lower median level in the AD versus non-AD groups (354+/-197 pg/ml versus 463+/-152 pg/ml). There were significant differences in both the median CSF Aß-42/t-tau ratio (3.6+/-2.7 versus 6.4+/-4.6; p = 0.03) and median Aß-42/p-tau ratio (8.4+/-4.1 & 13.8+/-7.1; p = 0.01) between AD patients and non-AD patients. After adjustment for age and gender, the Aß-42/p-tau ratio was an independent predictor of AD (p=0.02)
Conclusion
We conclude that the CSF Aß-42/p-tau ratio is a potentially useful diagnostic biomarker of AD in our Chinese population. In the future, a larger sample size of Chinese patients including more normal subjects, subjects with MCI or other forms of dementia is needed to indentify the local cut-off values of biomarkers in Chinese patients for clinical diagnosis in daily practice and in new clinical trials for new disease modifying agents these three biomarkers will also be useful as surrogate outcome measures. Standardization of the CSF processing and measurements is recommended to facilitate comparisons of these CSF biomarkers results between laboratories worldwide. ^^^^^^^^^^ 
OUTCOMES IN OLDER PEOPLE WITH STAGE 5 CHRONIC KIDNEY DISEASE -COMPARISON OF PERITONEAL DIALYSIS AND CONSERVATIVE MANAGEMENT
Background
Older people with stage 5 chronic kidney disease (CKD) are increasing. The benefits of dialysis for older people who are dependent and have multiple comorbidities are questioned when compared with conservative management. Previous overseas studies mainly focused on survival outcomes in older people receiving predominantly hemodialysis. Hong Kong has a peritoneal dialysis (PD)-first policy and if dialyze, most older people receive PD unless contraindicated.
Objectives The aims of this study are: (1) to compare the survival and non-survival outcomes in older people with stage 5 CKD receiving PD versus conservative management, and (2) to investigate the effect of age and other factors on the outcomes of PD Method This was a retrospective cohort study in older people (age ≥65 years) with stage 5 CKD receiving PD (PD group) compared with conservative management (conservative group). Baseline characteristics (demographics, clinical data, functional aspects, socio-economic factors and laboratory parameters) were collected and study outcomes (patient survival, all-cause and emergency hospitalization rates and hospital days, unplanned readmission rates, institutionalization, PD complications, palliative and end-of-life care) were recorded. 
Introduction
The use of antibiotics, artificial nutrition and hydration, mechanical ventilation, the appropriateness of repeated hospitalizations and 'active' treatment of life-threatening conditions are issues that medical staffs have to face day by day when dealing with patients. However, when treating terminally ill older patients, whether to employ the above or not usually depends on physicians' own perception of quality of life or on the principle of 'sanctity of life', and whether the treatment or investigations will be beneficial or burdensome to the patients. The definition of appropriate management of older patients with end-stage diseases is still debatable; therefore, sometimes physician may choose to do less for dying older patients to avoid futile treatments.1,2 In 1983, an observational study was done by Mills and his colleagues about the dying of patients in a hospital in Scotland. They described a disturbing scene of neglect and poor care of dying patients in busy acute medical wards. "Many of the medical staff tip-toeing past the closed curtains of a patient about to die in the belief that there was 'nothing more to be done' and that the patient was best left alone." 3 Unfortunately, this scene is still present in our daily practices. Despite general satisfaction with the treatment of medical problems, there is evidence of disappointment from patients and their families about the end of life care particularly with regard to symptoms control, and a failure to meet their physical and psychosocial needs in hospital in their final stage of life.4,5 Therefore, education of health-care professionals in promoting 'dying well' and the development of integrated end-of-life (EOL) care pathways for patients with end-stage diseases should be emphasized. 3 To ensuring that frail older patients can receive good quality of care in both acute and convalescent hospitals in their terminal stage of life is what a geriatrician must achieve. It includes offering adequate pain and symptoms control, respecting the older patients' dignity with a sense of control, avoiding inappropriate prolongation of their dying phase, relieving burden and strengthening rapport with the relatives.6,7 
^^^^^^^^^^
Background
Thrombotic thrombocytopenic purpura (TTP), is a thrombotic microangiopathic disorder, which carries a high mortality rate if left untreated. Most cases of acquired TTP arise from inhibition of ADAMTS13, a metalloprotease responsible for cleaving the von Willebrand factor. Although plasma exchange has greatly improved the outcome, treatment for refractory TTP is difficult and a wide range of additional approaches has been used, including immunosuppressive agents and monoclonal anti-CD20 antibodies.
Objectives This study aimed to evaluate any possible factors that may predict mortality and risk of relapse of patients with TTP. Clinical features and treatment regimen were also described.
Method
Case records of all patients diagnosed TTP presenting to our local hospitals from January 2000 to June 2011 were retrospectively reviewed. Their demographic characteristics, clinical features, treatment regimen and clinical outcomes were analyzed.
Results Fifty-five patients were included in the study. Plasma exchange therapy was performed in 53 (96.4%) patients, with 40 (72.7%) patients achieved remission. Fifteen (27.3%) patients died during the acute episode of TTP. Multivariate logistic regression model showed that neurological abnormalities at presentation was predictive of the initial hospitalisation mortality of TTP. Also the mean of the presenting creatinine of the deceased group was higher than the survivor group (268 + 185 vs 183 + 134, p = 0.01) during the acute episode. The time lapse between diagnosis and treatment appeared to be longer in the deceased group when compared with the survivor group (20.3 + 28.4 hours vs 11.6 + 19.4 hours), but it was not statistically significant (p = 0.27). After a median follow-up of 35 months (range: 2 -124 months), 7 of 40 (17.5%) patients who attained remission after initial treatment suffered from relapse of TTP.
Conclusion
Plasma exchange remains the mainstay of treatment for TTP. In patients with neurological abnormalities at presentation and markedly impaired renal function, a more intensive course of treatment might be considered. Further studies in identifying risk factors for refractory/relapsing TTP is beneficial. Human immunodeficiency virus (HIV) infection resulted in immune dysfunction and higher incidence of malignancies was observed. With the advancement of highly active anti-retroviral therapy (HAART), life expectancy of HIV infected individuals has been improving due to the reduction in opportunistic infection. Therefore, more attention is required in the optimal management of long-term complications of HIV infection, including HIV-associated lymphoma.
Objective To study the epidemiology, treatment outcome and complications of HIV-associated lymphoma.
Method
Retrospective analysis of patients diagnosed with HIV-associated lymphoma between Jan 1995 and Oct 2011 was performed. Demographic and clinical characteristics of eligible patient were reviewed. Treatment outcome in terms of complete remission rate and overall survival were assessed. Baseline characteristics, treatment response and adverse events were compared to HIV-negative lymphoma control patients.
Results
Fifty-seven HIV-associated lymphoma cases were identified and analyzed. 
Conclusion
Patient with HIV-associated lymphoma tend to present with advance stage disease. More patients suffered from bone marrow and extra-nodal involvement on presentation. CR rate in HIV-associated DLBCL and BL were comparable to the HIV-negative control groups (p=0.379 and p=1.0 respectively). The 5-year survival in HIV-associated BL and HIV-negative BL control were similar (p=1.00). However, the OS in HIV-associated DLBCL was inferior to HIV-negative control group (p=0.011). Further study with larger number of patients is required to identify risk factors associated with inferior outcome and to look into strategies that can improve OS in HIV-associated DLBCL patients. Results Ninety-four patient-episodes of candidaemia were reviewed. Fifty-one (54.3%) was Candida albicans bloodstream infections and Candida glabrata was the leading cause of nonalbicans infections. Fifty-two (55.3%) patients were admitted to ICU during the hospital stay, with median length of ICU stay of 11 days (range: 2-50). The median length of hospital stay was 36 days (range: 1-253). The main antifungal therapy prescribed were fluconazole and amphotericin B deoxycholate. Echinocandins were used more oftenly in the later years of study period. The crude hospital mortality was 62.8% and 90-day mortality was 70.2%. Mortality was associated with presence of shock and vasopressor use prior to candidaemia, absent or delayed clearance of candidaemia and prior use of systemic steroids. By multivariate analysis, prior use of systemic steroids (OR: 6.803; 95% CI: 1.471, 31.459) and clearance of fungaemia within 7 days of blood sampling (OR: 0.239; 95% CI: 0.087, 0.657) were independently associated with increased and decreased hospital mortality respectively.
Conclusion Candidaemia was associated with high mortality and prolonged hospital stay. Candida albicans was still the predominant species despite non-albicans species candidaemia was increasing in incidence. Clinical awareness and recognition of importance of prompt antifungal therapy with complications screening needed to be reinforced. ^^^^^^^^^^ Methods We performed a retrospective study to evaluate the 12 months efficacy and safety after conversion to PSI in renal transplant recipients in Princess Margaret Hospital since 2004.
LOCAL EXPERIENCE OF PROLIFERATION SIGNAL INHIBITOR IN RENAL TRANSPLANT RECIPIENTS
Results
Renal function determined by creatinine clearance was significantly better in the PSI group (55.51±18.43ml/min at baseline vs 60.03±20.24 at one year, p=0.03). The incidence of biopsy-proven acute rejection after conversion was not different from the other trials. Increase in proteinuria and lipid were more significant after PSI conversion.
Conclusions
Conversion to PSI may be a useful strategy to improve renal function. The adverse effects are usually well tolerated. Early conversion may be more beneficial than late conversion. Appropriate selection of candidates for PSI conversion, and early identification and prompt management of PSI induced adverse events, reduce serious complication and improve outcome. Background Nocturnal home haemodialysis (NHHD) has shown promising clinical results in various clinical surrogate parameters and patient survival. Whether NHHD has sustained benefit in anaemia management is conflicting. We performed a retrospective case-control cohort study to investigate the effect of NHHD in renal anaemia.
^^^^^^^^^^
EFFECT OF NOCTURNAL HOME HAEMODIALYSIS ON ANAEMIA CONTROL IN PATIENTS WITH END-STAGE RENAL DISEASE
Objective This controlled study aims to investigate whether anaemia and erythropoietin requirement are improved in NHHD patients compared with conventional haemodialysis (CHD); and whether the benefit will extend beyond first year of treatment.
Method
We retrospectively reviewed the records of patients receiving NHHD on alternate nights for over two years. Matched control was identified from in-centre CHD patients. Haemoglobin level and erythropoietin requirement during the study period were recorded and compared between the two groups. Iron indexes and dialysis adequacy were compared as secondary outcomes.
Results Twenty-three NHHD patients were matched with 25 CHD patients with comparable baseline parameters. Haemoglobin level increased from 9.37 ± 1.39 g/dL to 11.34 ± 2.41 g/dL (p < 0.001) in NHHD group and erythropoietin requirement decreased from 103.44 ± 53.55 U/kg/wk to 47.33 ± 50.62 U/kg/wk (p < 0.001) after two years. There was further reduction in erythropoietin requirement after first year of NHHD (p = 0.037). Twenty-six per cent of patients in NHHD group stopped erythropoietin. Comparing the two groups at the end of study period, haemoglobin level was significantly higher in NHHD group (11.34 ± 2.41 g/dL in NHHD vs. 9.34 ± 1.65 g/dL in CHD; p = 0.001) and erythropoietin requirements significantly lower in NHHD group (47.33 ± 50.62 U/kg/wk in NHHD vs. 105.92 ± 36.91 U/kg/wk in CHD; p < 0.001). Ferritin level was lower in NHHD group at the end of 2 years (541.35 ± 396.52 pmol/L in NHHD vs. 913.88 ± 791.12 pmol/L in CHD; p = 0.044) yet it remained within recommended range. Iron saturation did not change and there was no difference between two groups. Weekly single-pool Kt/V was significantly higher in NHHD group (9.85 ± 4.04 in NHHD vs. 3.74 ± 1.91 in CHD; p < 0.001). Conclusion: NHHD with an alternate night schedule improves anaemia control and reduces erythropoietin requirement when compared with CHD. Erythropoietin requirement is further reduced after one year of NHHD. When compared with CHD, patients on NHHD have 2.6 times higher weekly single-pool Kt/V. NHHD patients have lower ferritin level, but there is no difference in iron saturation. 
Background and purpose
Dementia poststroke is believed to be due to cerebrovascular lesions (i.e. vascular dementia), concurrent Alzheimer's disease (AD) or mixed vascular and Alzheimer's pathology (i.e. mixed dementia). To differentiate the various etiologies based on clinical features and standard structural imaging is difficult. We aimed to determine the prevalence of concurrent Alzheimer's pathology (i.e. amyloid plaques) using Pittsburg Compound B (PiB) PET imaging; and to examine any differences in the clinical, radiological and cognitive profiles between subjects with and without amyloid plaques.
Methods Consecutive patients admitted to our acute stroke unit with first-ever or recurrent stroke or transient ischemic attack (TIA) over a 24 months period were invited for a brief neuropsychological assessment 3 -6 months poststroke. Subjects who completed this first assessment were reassessed 1 year later (i.e. 15-18 months poststroke). Patients were recruited if a diagnosis of dementia was made according to Diagnostic and Statistical Manual (4th edition), or when there is a drop of ≥3 points in the mini-mental state examination (MMSE) between the first and second assessment. We performed detailed clinical, radiological and neurospyschological assessments including the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-cog). PiB and FDG PET imaging were arranged after informed consent from the subjects and their caregivers.
Results Out of the 63 recruited subjects, 14 (22.2%) demonstrated AD-like PiB retention. In terms of cognitive profile, patients in the PiB-positive group seemed to score worse than the PiB-negative group in terms of delayed word recall (10.0 versus 10.0, p=0.083) and ideational praxis (1.0 versus 2.0, p=0.080). In terms of medial temporal lobe atrophy, there was no significant difference in the severity of MTLA between the two groups (right side 1.0 versus 2.0, p=0.621; left side 1.0 versus 2.0, p=0.286).
Conclusion
It is feasible to use PiB PET imaging to differentiate the underlying aetiology of poststroke dementia with greater accuracy than can be accomplished based on the clinical phenotype. We found that PiB retention typical to that of AD was found in about one fifth of patients with either early PSD or delayed poststroke cognitive decline. Background Patients who are admitted for acute ischaemic stroke often have residual neurological deficits and other comorbidities, which may lead to an increased risk of hospital readmission. This study looked for the predictors and the causes of hospital readmission within the first year of discharge for index ischaemic stroke.
^^^^^^^^^^
PREDICTORS AND CAUSES OF HOSPITAL READMISSIONS AFTER ACUTE ISCHAEMIC STROKE: A LOCAL COHORT STUDY
Methods One-thousand seven hundred and ninety-seven patients were admitted to Tuen Mun Hospital from January 1, 2009 to December 31, 2009 for acute ischaemic stroke. Four hundred of these patients were sampled by simple randomization for retrospective cohort analysis. Their hospital records were studied in detail. The time to their next hospitalizations within the first year after hospital discharge was determined. These patients were then dichotomized into those with hospital readmission and those without. Their clinical data were collected and analyzed for the predictors and the causes of next hospital readmission.
Results A total of 400 patients were studied in detail, but after exclusion, 334 patients were recruited for this study. One-hundred and sixty-eight patients (50.3%) were found to have hospital readmission in the first year of discharge for index acute ischaemic stroke. The predictors of hospital readmission included old age >72 years (odds ratio [OR], 1.7; 95% confidence interval [CI], 1.037 to 2.733; p=0.001), cardioembolic stroke (OR, 5.0; 95% CI, 1.558 to 16.082; p = 0.007), diabetes mellitus (OR, 2.1; 95% CI, 1.169 to 3.817; p = 0.035), complications occurring during index admission (OR, 1.9; 95% CI, 1.218 to 3.117; p = 0.013), and NIHSS > 5 (OR, 2.7; 95% CI, 1.654 to 4.321; p < 0.001). Among these patients, 50 (14.9%) of them were readmitted early within the first month, and 118 (35.5%) were admitted late. Predictors of early readmission included those who were not discharged home, but to an institution (OR, 3.0; 95% CI, 1.255 to 7.34; p = 0.013), NIHSS > 5 (OR, 3.4; 95% CI, 1.599 to 7.322; p = 0.001), and diabetes mellitus (OR, 2.2; 95% CI, 1.113 to 4.545; p = 0.023). Predictors of late readmission include those with ischaemic heart disease (OR, 2.0; 95% CI, 1.002 to 4.038; p = 0.048), cardioembolic stroke (OR, 6.4; 95% CI 1.969 to 20.943; p = 0.001), any complications that arose during index admission (OR, 2.1; 95% CI, 1.135 to 4.056; p = 0.018), age > 72 years (OR, 1.9; 95% CI 1.15 to 3.26; p = 0.013), and NIHSS > 5 (OR, 2.2; 95% CI, 1.328 to 3.807; p = 0.002). The commonest causes of hospital readmission were infection and recurrent stroke.
Conclusion
Patients who were admitted to hospital for acute ischaemic stroke are at increased risk of readmission after the index event. There were different risk factor profiles of early hospital readmission (within the first month) and late hospital readmission (2 months to 1 year). These findings may help us to identify high risk patients so that we may enhance their postdischarge care plan in order to improve their physical conditions and prevent rehospitalization. Background Occlusive radiation vasculopathy (ORV) predisposes survivors of head-and-neck cancers to refractory ischemic strokes.
Understanding the angiographic attributes and collateral circulations of ORV may help to elucidate the stroke mechanism.
Methods From September 2005 to February 2012, we recruited 92 patients who developed first-ever ischemic stroke attributed to ORV for digital subtraction angiogram (DSA). Another 112 patients who had symptomatic carotid stenosis (>70%) without prior radiotherapy were enrolled within the same period as referent subjects. DSA was performed within 2 months from the stroke onset and delineated carotid and vertebro-basilar circulations from aortic arch up to intracranial branches. A stroke neurologist and a neuro-radiologist blinded to group assignment categorized all vascular lesions, graded the collateral status, and recorded the anatomic variants that might forbid or mimic collateral development.
Results ORV patients were younger and had significantly less atherosclerotic risks in terms of hypertension, diabetes mellitus and hyperlipidemia. The mean interval between RT and stroke was 15 years (IQR 9.8 years). In contrast to referent subjects who mostly had focal high-grade (>70%) steno-occlusion at proximal internal carotid artery (123/143, 86%), stenoses in ORV patients tended to diffusely involve common carotid artery (70/176, 40%) and internal carotid artery (63/176, 36%), and were more frequently bilateral (53% vs 23%), tandem (23% vs 10%) and with concurrent vertebral artery steno-occlusions (27% vs 14%) (All p<0.05). ORV patients also showed more dissecting and ulcerative lesions. With comparable rates of vascular anomaly, ORV patients had more established collateral circulations through leptomeningeal arteries and retrograde flow of ophthalmic artery.
Compared with spontaneous atheromatous carotid disease, ORV patients had more steno-occlusions over carotid and vertebral arteries amid mature collateral circulations at stroke onset. Decompensation of collateral flows may precipitate stroke in ORV. 
^^^^^^^^^^
SEROPREVALENCE OF AQUAPORIN-4 ANTIBODY IN OPTIC NEURITIS PATIENTS AND ITS CLINICAL CORRELATION -ANALYSIS OF
Background
Epidemiologic studies have suggested different prevalence of aquaporin-4 antibody in optic neuritis patients in different ethnic groups. However, data on the prevalence of aquaporin-4 antibody in Hong Kong is scarce. The clinical significance of aquaporin-4 antibody in optic neuritis patients is also unknown.
Objective To obtain the prevalence of aquaporin-4 antibody in patients with optic neuritis in Hong Kong Chinese and to evaluate the clinical significance of aquaporin-4 antibody in optic neuritis patients.
Methods This is a single centre prospective cohort study. We prospectively recruited and followed up a total of 22 optic neuritis patients from November 2010 to December 2011 in the Kowloon West Cluster of Hong Kong Special Administrative Region (HKSAR), China. The detection of aquaporin-4 antibodies was by indirect immunofluorescence method using monkey cerebellar transfected HEK293 cells which express human aquaporin-4 on their cell membranes. The relation between the clinical diagnosis and the aquaporin-4 antibody serologic status was analysed.
Results Among the 22 optic neuritis patients which constituted 27 episodes of acute neuritis, 4 (18.2%) were tested to be aquaporin-4 antibody positive. Three out of the 22 optic neuritis patients fully met the 2006 Wingerchuk Criteria and were diagnosed to have neuromyelitis optica (13.6%), in which 2 of them were tested positive for aquaporin-4 antibody. Among the 4 seropositive patients, 75% of them developed recurrent optic neuritis (p<0.02). All 4 seropositive patients developed thinning of retinal nerve fibre layer thickness (55.4+/-15.85) compared to the seronegative group (89+/-7.5). All of the seropositive patients developed severe visual impairment (20/200) (p=0.002), with visual acuity of 0.36+/-0.3, in contrast to 0.59+/-0.14 in the seronegative group at 3-month follow up (p=0.446). Five out of the 22 patients had recurrent optic neuritis, in which 3 of them were tested positive for aquaporin-4 antibody. Bilateral eye involvement was found in 3 out of the 4 (75%) seropositive patients and in 2 out of the 18 (11.1%) seronegative patients respectively (p=0.023). Diagnosis of multiple sclerosis was made in 13.6% of all optic neuritis patients. Among the seropositive patients, 25% of the seropositive group had the presence of cerebrospinal fluid pleocytosis (p=0.4) while none of them showed oligoclonal band (p=0.66).
Conclusion
The prevalence of aquaporin-4 antibody in Hong Kong Chinese optic neuritis patients is halfway in between the data from Caucasian and Asian population. The seropositivity of the test was associated with bilateral optic nerve involvement, higher chance of recurrent optic neuritis and more severe reduction of optic nerve fibre layer thickness. ^^^^^^^^^^ 
SYMPTOM BURDEN, DEPRESSION AND SUICIDALITY IN CHINESE ELDERLY PATIENTS SUFFERING FROM ADVANCED CANCER
Background
Despite serious concern over the suicidality of cancer patients in palliative care practice, few studies have addressed this issue. With the expected growth of geriatric population in our locality, more elderly advanced cancer patients were expected to be under palliative care. This study aimed to measure the symptom burden, prevalence of depression and suicidal ideation of Hong Kong Chinese elderly suffering from advanced cancer, and to identify the correlation of symptom burden and depressed mood with suicidality.
Study Design
The study adopted a cross-sectional design and recruited consecutive series of Chinese elderly aged 65 or above with advanced cancer who had been admitted to the Palliative Medical Unit of the Grantham Hospital during the study period from 1 st March 2011 to 31st December 2011. Patients recruited were in their palliative phase of disease. Recruited patients were asked to complete a battery of questionnaires. The Edmonton Symptom Assessment Scale (ESAS) has been adopted to measure the symptom prevalence among the subjects. The Geriatric Depression Scale-short form (GDS-SF) was used to assess the depressive symptoms, while Item 3 of Hamilton Rating Scale for Depression (HRSD) was used to measure the extent of suicidality.
Results
A total of 52 elderly patients with advanced cancer were interviewed, with 11 patients being excluded because of poor physical condition, language barrier and cognitive impairment. Forty-one eligible patients were recruited and all of them had completed the questionnaires. The mean score of Edmonton Symptom Assessment Scale-Symptom Distress Score (ESAS-SDS) was 36.9 (SD=15.3). Among the individual items, fatigue was the most prevalent symptom and was present in 92.7% of subjects, with a mean score of 5.6 (SD=2.8). The frequency of most symptoms and overall symptom distress score were similar to previous studies using ESAS as symptom measurement in palliative cancer patients. However, our study targeting at elderly patients reported a lower pain score (mean=2.6, SD=2.6) when compared with previous studies. Using the GDS-SF score ≧8 as a screening cut-off point, significant depressive symptoms were common (43.9%) in this group of patients, and was remarkably higher than previous local studies targeting at general geriatric population. Besides, up to 46.3% (n=19) of patients reported presence of suicidality, with 14.6% (n=6) having had active suicidal idea or attempted suicide. There was a statistically significant positive correlation found between fatigue (r=0.38, p<0.05), depression (r=0.61, P<0.01), anxiety (r=0.47, p<0.01), wellbeing (r=0.65, p<0.01) and symptom distress score (r=0.71, p<0.01) in Edmonton Symptom Assessment Scale with suicidality. GDS-SF score also demonstrated strong positive correlation with suicidality (r=0.79, P<0.01). After multiple regression analysis on the suicidality measurement on Item 3 of HRSD, GDS-SF score remained statistically significant and accounted for 61.7% of the total variance of suicidality.
Conclusion
Elderly patients with advanced cancer had significant symptom burden comparable to western studies. Fatigue was the most prevalent symptom. When compared with previous local studies targeting at general geriatric population, a much higher rate of depression and suicidal ideation was found in our study group. Depressive symptom was the most important independent factor for suicidality in this group of patients.
Implications
The results of this study draw the attention of palliative care workers to the importance of mood and suicidality assessment in our daily care of advanced cancer elderly patients. The results help physicians to identify the group of patients that is particularly vulnerable to suicidal ideation. By using GDS-SF and HRSD-Item III as screening tools, it helps to identify depressed patients possessing suicidal idea who need specialist care. As more attention are drawn towards end-of-life care for our ageing population, medical workers should receive appropriate training in this area and team collaboration with psychiatric unit is warranted. Objective To assess the disease spectrum, severity, admission numbers, co-morbidities and management pattern of in-hospital COPD patients in an acute regional hospital.
Method COPD patients admitted to the Alice Ho Miu Ling Nethersole Hospital (AHNH) during January 2010 to December 2010 were recruited. Demographic data, exacerbations frequency and spirometry data were assessed. The usage of acute or long term non-invasive ventilation (NIV), long term oxygen therapy (LTOT), and prescription of medications based on spirometry values available were also recorded.
Result 253 patients were included in the study with mean age 78.4. The mean number of admissions due to COPD exacerbation was 1.96 and 54.2% had one admission in 2010. Two-third (64%, n=162) had at least one spirometry done in or before 2010. Mean forced expiratory volume in one second was 1.02 liters (SD +/-0.425 liters) and the FEV1 (% predicted) was 54.9%. 10.5% (n=17) belonged to Global Initiative for Chronic Obstructive Lung Disease stage 1, 42% (n=68) belonged to stage 2, 37% (n=60) belonged to stage 3 and 10.5% (n=17) belonged to stage 4. Short acting bronchodilators and oral theophylline were commonly use. Long acting bronchodilators like long-acting beta-agonist (LABA) and long-acting muscarinic antagonist (LAMA) were being prescribed in 16.6% (n=42) and 6.7% (n=17), respectively.
Conclusion Most of our patients were old with majority belonging to moderate and severe COPD groups. Significant proportion had at least 2 or more admissions in 2010. The adherence to latest treatment guidelines seemed inadequate with low prescription rate of long acting bronchodilators. Background Acute chronic obstructive pulmonary disease (COPD) exacerbations often leave considerable effects on patients' lung function and health status. An educational approach that encourages patients to detect changes in symptoms and empowers patients to self-manage exacerbations early has the potential to improve exacerbation outcomes and reduce healthcare utilisation. At North District Hospital, a Respiratory Collaborative Care Team (RCCT) was established in 2009 to support patients in self-management that includes education on the use of stand-by courses (crisis management packs) of antibiotics and corticosteroids. Objectives 1. To study the effect of a COPD self-management programme on healthcare utilisation2. To study the safety issues of self-administered corticosteroids and antibiotics Methods Clinical records of RCCT patients prescribed crisis packs from January 2009 to December 2010 were reviewed. Demographics and characteristics of patients, number of hospital admissions and emergency department visits, causes of admissions one year before and after the start of crisis pack prescription were analysed. Incidence of pneumonia and adrenal insufficiency and emergence of drug-resistant respiratory pathogens after the practice of crisis pack prescription were reviewed.
Results A total of 316 patients had been prescribed crisis packs during the study period and 167 patients were eligible for analysis. Health care utilisation rate, including both hospitalisations and Accident and Emergency Department (AED)visits related to COPD, was significantly reduced by 29.2% (p<0.001) after crisis pack introduction. COPD-related hospitalisation was also significantly reduced by 34.5% (p<0.001). Mean incidence of pneumonia was similar before and after crisis pack practice (0.14 vs 0.13, p=0.752). Three patients (1.4%) had antimicrobial resistance that developed in the same species of respiratory pathogens and 30 patients (9.5%) had acquired a new resistant pathogen. Three patients developed adrenal insufficiency requiring oral hydrocortisone supplement.
Conclusion An educational programme that empowers patients to self-manage COPD exacerbation with crisis pack successfully reduced the health care utilization. However, risks associated with the development of resistant respiratory pathogens and adrenal insufficiency remain. Background COPD patients who suffer from exacerbation with acute hypercapnic respiratory failure (AHcRF) benefit from non-invasive ventilation (NIV). The best withdrawal method of NIV is however not known. We designed a study comparing stepwise withdrawal versus immediate withdrawal of NIV to assess the success rate of withdrawal of NIV after recovery of AHcRF.
Method This was a prospective, single-centre, open-labelled randomised study comparing stepwise withdrawal of NIV and immediate withdrawal of NIV in patients with COPD exacerbation recovering from AHcRF. The primary end-point was the success rate of NIV withdrawal.
Results Sixty patients were randomised: 35 patients to the stepwise withdrawal group and 25 patients to the immediate withdrawal group. Six patients in the stepwise withdrawal group were withdrawn after randomisation (5 withdrew consent and 1 patient had concurrent metabolic acidosis). The two study arms were well balanced demographically. There was no statistically significant difference in the success rate of withdrawal of NIV and length of stay after randomisation, with the success rate of 74.3% and 56% in stepwise and immediate withdrawal group respectively (p = 0.139). There was statistically significant difference in the duration of NIV with median duration of 5 days and 3 days in stepwise and immediate withdrawal group respectively (p = 0.001).
Conclusion
Our study showed no statistically significant difference in the success rate and length of stay between stepwise withdrawal and immediate withdrawal of Results 172 and 41 patients were diagnosed with pulmonary tuberculosis and tuberculous effusion respectively. For pulmonary tuberculosis, 59% were diagnosed in the same admission. Sputum acid fast bacilli (AFB) smear was the commonest method of diagnosis. Nucleic acid amplification test accounted for 9.3% of the cases. For tuberculous effusion, pleural biopsy histology was the most common diagnostic method. The sensitivity of pleural fluid adenosine deaminase was 78%. Patients not diagnosed with pulmonary tuberculosis in the same admission were older (P=0.001), more likely to be AFB smear negative (P<0.001), had single lung involvement (P=0.007), had no cavities on X-ray (P=0.018), stayed longer in hospital (P=0.001) and died (P=0.037).
Almost half of the patients admitted were not diagnosed in the same hospital admission, which was associated with high inpatient mortality. Background Patients with spontaneous pneumothorax are at risk of recurrence. Pleurodesis is recommended for patients with recurrent primary spontaneous pneumothorax or secondary spontaneous pneumothorax. However, surgical pleurodesis carries high mortality and morbidity in patients with poor lung reserve or multiple underlying medical illnesses. Non-surgical chemical pleurodesis is a safer procedure for these patients. Many factors such as concomitant use of steroid may decrease the success rate of chemical pleurodesis.
